International Federation of Pharmaceutical Manufacturers and Associations
79th WHA Individual Statements
IFPMA believes a stronger global health architecture should foster innovation, strengthen health systems so innovations reach people, and forge partnerships to advance health globally.
For a joint process to succeed, three safeguards are essential.
o First, it should clarify mandates, comparative advantages and decision pathways across institutions, including how recommendations affecting organizations beyond WHO would be considered by their governing bodies.
o Second, it should ensure balanced participation, with the private sector included alongside civil society in core structures, including the joint task force and any time-limited working groups where relevant
o Third, product innovation and access should remain within WHO’s constitutional and Member State-mandated functions, and should not drift into IP, licensing, pricing, procurement, manufacturing, or supply decisions.
IFPMA stands ready to contribute.